Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 2016

Brand Judith S, Hedayati Elham, Humphreys Keith, Ludvigsson Jonas F, Johansson Anna L V, Bergh Jonas, Hall Per, Czene Kamila

Abstract excerpt

PURPOSE: Venous thromboembolism (VTE) is highly heritable and a serious complication of cancer and its treatment. We examined the individual and joint effects of chemotherapy and genetic susceptibility on VTE risk in patients with breast cancer. EXPERIMENTAL DESIGN: A Swedish population-based study including 4,261 women diagnosed with primary invasive breast cancer between 2001 and 2008 in Stockholm, followed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Risk Factors

Share to Survival Analysis

Share to Sweden

Share to Venous Thromboembolism

Source

Identifiers

PMID: 27803117
DOI: 10.1158/1078-0432.CCR-16-1110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.PMID 27803117Read ↗

[The genetics of thrombosis in cancer].Semantic proximity Read ↗

Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort studySemantic proximity Read ↗

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.Semantic proximity Read ↗

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.Semantic proximity Read ↗

Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.Semantic proximity Read ↗

Potential utility of comprehensive genomic profiling to predict venous thromboembolism in patients with solid cancer.Semantic proximity Read ↗

Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.Semantic proximity Read ↗

Prediction of primary venous thromboembolism based on clinical and genetic factors within the U.K. Biobank.Semantic proximity Read ↗

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.Semantic proximity Read ↗

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.